“Vitamin C” on a product page can refer to L-ascorbic acid or a chemically modified derivative designed for a different formulation environment. The derivative may be water soluble or oil soluble, may require conversion in skin, and may have evidence for a different outcome. This database maps what type of evidence is available and—equally important—what it cannot establish.
For a basic chemistry comparison, see L-ascorbic acid versus vitamin C derivatives. For ingredient-name checking, use GlowBareSkin’s INCI alias database.
Evidence map: molecule before marketing category
How this database grades evidence
Each entry separates five questions:
- Identity: Which exact molecule was studied?
- Delivery: Was the work about stability, release, penetration or a human outcome?
- Isolation: Was the derivative tested alone, against vehicle, or inside a multi-ingredient formula?
- Endpoint: Acne lesions, pigmentation, wrinkles, hydration and laboratory antioxidant activity are not substitutes for one another.
- Transferability: Does the concentration, vehicle, population and use resemble the product being discussed?
The map intentionally avoids a single numeric score. A controlled acne trial may be strong for that lotion and endpoint while being indirect for an anti-ageing serum. Evidence strength is claim-specific.
Vitamin C derivative reference database
| Derivative | What the literature supports | Important limitation |
|---|---|---|
|
Sodium ascorbyl phosphate (SAP) Also reported as sodium L-ascorbyl-2-phosphate or APS |
A randomized, double-blind, vehicle-controlled 12-week trial evaluated a 5% SAP lotion in 50 participants with acne and reported improvement across measured parameters. A separate clinical formulation study compared 5% SAP and ascorbic-acid emulgels for wrinkle and elasticity endpoints. | The acne result belongs to one 5% lotion and population. It does not prove that every SAP concentration, vehicle or cosmetic product produces the same outcome. |
| Magnesium ascorbyl phosphate (MAP) | Older work reports effects on melanogenesis models and absorption in human skin. Human studies include specialized carriers and combinations with light-based procedures. | When MAP is paired with fluorescent pulsed light, ultrasound, nanoparticles or another active, the derivative’s independent contribution cannot be isolated. |
|
Ascorbyl glucoside (AA2G) Often listed as ascorbyl glucoside |
Permeation research has tracked breakdown to ascorbic acid. Human work often tests ascorbyl glucoside with niacinamide, ultrasound, other brightening agents or a modified complex. | Evidence for a device-assisted or multi-ingredient system is formula evidence, not proof of the derivative alone. |
|
3-O-ethyl ascorbic acid (3-O-EAA) Also called ethyl ascorbic acid |
Laboratory studies address melanogenesis, antioxidant mechanisms and skin uptake. A 2019 study found skin uptake without permeation through the tested skin model; newer delivery studies examine retention in porcine skin. | Uptake, retention and cell-model activity are not equivalent to randomized human evidence for visible pigmentation or wrinkle outcomes. |
|
Tetrahexyldecyl ascorbate (THD/THDC) Oil-soluble derivative |
Published work includes stability research and open-label studies of formulas containing THD ascorbate with other ingredients. A 2021 study reported rapid degradation under some storage conditions. | Oil solubility does not automatically establish superior penetration or efficacy. Open-label, multi-ingredient formulas cannot isolate THD ascorbate’s effect. |
| Ascorbyl palmitate | Literature includes formulation, carrier, penetration and cell-model studies. It is a lipid-soluble ester used as an antioxidant in formulations. | Human topical outcome evidence is comparatively sparse, and in-vitro photoreactivity findings cannot be translated directly into routine consumer use without formulation context. |
Entry 1: sodium ascorbyl phosphate
SAP has one of the clearer molecule-specific human records among the derivatives in this database. Woolery-Lloyd and colleagues randomized 50 participants to 5% SAP lotion or vehicle for 12 weeks. The report describes blinded comparison, lesion counts and tolerability. This makes it relevant to the tested acne outcome—not a universal brightening or anti-ageing claim.
Mohammadi and colleagues later evaluated 5% SAP and L-ascorbic-acid emulgels, including stability testing and crow’s-feet outcomes. The abstract reports improvement but no statistically significant efficacy difference between the active preparations. Formulation, refrigeration and stabilizing antioxidants were part of that study context.
Entry 2: magnesium ascorbyl phosphate
Kameyama and colleagues reported suppression of melanin formation in laboratory models and examined absorption of a MAP cream. That supports biological plausibility. It does not, on its own, quantify a visible consumer result.
A 2014 trial combined topical 5% MAP with fluorescent pulsed light in patients with refractory melasma. Because the design tested a combination, its result should be written as combination evidence. A newer carrier study compared MAP vesicular gels, again making vehicle and delivery system part of the interpretation.
Entry 3: ascorbyl glucoside
Ascorbyl glucoside is frequently studied inside a system. Hakozaki and colleagues evaluated high-frequency ultrasound with a gel containing ascorbyl glucoside and niacinamide. The device enhanced absorption and the combined protocol reduced hyperpigmented spots compared with controls. This cannot tell us how much effect came from ascorbyl glucoside alone.
Mass-spectrometry work has detected ascorbyl glucoside and its breakdown into ascorbic acid in skin. This strengthens delivery plausibility, while still leaving formulation-level human efficacy as a separate question.
Entry 4: 3-O-ethyl ascorbic acid
3-O-EAA is relevant to GlowBareSkin because ethyl ascorbic acid appears in the Night Elixir formula. That presence should not be used to claim that the product reproduces isolated-ingredient studies. A 2019 characterization study examined stability and skin uptake. A 2021 paper investigated anti-melanogenic mechanisms, while 2024 work studied release and retention from lipid gels using synthetic membranes and porcine skin.
The accurate summary is that mechanistic and delivery research exists, but direct, independently replicated, randomized human evidence for specific visible outcomes remains more limited than marketing language often suggests.
Entry 5: tetrahexyldecyl ascorbate
THD ascorbate is often marketed around oil solubility. Solubility is a formulation property, not an efficacy result. Swindell and colleagues found that THDC degraded rapidly under tested conditions, challenging blanket “stable vitamin C” descriptions. Human studies located commonly use open-label designs or multi-ingredient formulas, which are useful for formula performance but cannot isolate one derivative.
Entry 6: ascorbyl palmitate
Ascorbyl palmitate has been investigated in carrier systems and cell models. A 2002 keratinocyte study reported pro-oxidant effects under its specific UVB experimental conditions, illustrating why “antioxidant” is not a universal behavior independent of dose, light, model and formulation. That study should not be converted into a blanket consumer-safety claim.
How to read a vitamin C product label
- Find the exact INCI name. “Vitamin C” on the front panel is not enough.
- Confirm the percentage only when the brand discloses it. Ingredient order cannot reveal an exact concentration.
- Inspect the whole formula. Vehicle, pH, water activity, antioxidants, chelators and packaging influence stability and delivery.
- Match the claim to the evidence. An acne trial does not establish wrinkle reduction; a penetration study does not establish brightening.
- Watch for multi-ingredient borrowing. A formula result should not be assigned to the derivative unless the design isolates it.
GlowBareSkin’s ingredient concentration database and cosmetic claims evidence database provide additional checks.
Citation desk
| Carefully scoped fact | Primary source | What it cannot prove |
|---|---|---|
| A 5% SAP lotion was tested against vehicle for acne over 12 weeks in 50 participants. | Woolery-Lloyd et al., 2010 | All SAP products or non-acne outcomes. |
| 5% SAP and ascorbic-acid emulgels were studied for stability and crow’s-feet endpoints. | Mohammadi et al., 2021 | Equivalence across unrelated commercial formulations. |
| MAP affected melanogenesis models and was examined in human skin. | Kameyama et al., 1996 | A guaranteed clinical brightening effect. |
| Ultrasound enhanced delivery from a gel containing ascorbyl glucoside and niacinamide. | Hakozaki et al., 2006 | The isolated effect of ascorbyl glucoside. |
| 3-O-EAA showed skin uptake in an in-vitro permeation model. | Iliopoulos et al., 2019 | A visible outcome in users. |
| THDC degraded rapidly under conditions tested in a stability study. | Swindell et al., 2021 | The shelf stability of every packaged THD formula. |
| Ascorbyl palmitate showed UVB-related photoreactivity in keratinocytes under experimental conditions. | Meves et al., 2002 | Routine consumer harm or finished-product performance. |
Methodology, provenance and limitations
This evidence database used PubMed-indexed primary studies and peer-reviewed reviews to locate topical molecule-specific evidence. Entries were grouped by the most direct evidence located, not by popularity or commercial positioning. It was reviewed on 16 August 2026. It is a structured narrative evidence map, not a systematic review or meta-analysis; relevant studies may exist outside indexed sources, and new research can change the map. No GlowBareSkin product testing or proprietary dataset was used.
Suggested citation: Bathula Meghana, “Vitamin C Derivatives for Skin: Evidence Database,” GlowBareSkin, reviewed 16 August 2026.
Frequently asked questions
Which vitamin C derivative has the best evidence?
There is no context-free winner. SAP has controlled human evidence for a specific 5% acne lotion; other derivatives have evidence for different outcomes and delivery systems. Match the molecule and study to the claim.
Are derivatives more stable than L-ascorbic acid?
Some derivatives can be more stable in particular systems, but stability depends on solvent, pH, temperature, light, oxygen, packaging and time. “Derivative” does not guarantee stability.
Does a derivative convert to ascorbic acid in skin?
Conversion or breakdown has been demonstrated for some derivatives in specific models. The rate and extent depend on the molecule and formulation, and conversion evidence alone does not quantify a visible outcome.
Can I compare percentages across derivatives?
Not directly. Molecular weight, solubility, conversion, vehicle and endpoint differ. Five percent SAP is not biologically interchangeable with five percent MAP, AA2G or THD ascorbate.
Is ethyl ascorbic acid proven for pigmentation?
Mechanistic and delivery research is encouraging, but randomized molecule-specific human outcome evidence is comparatively limited. Product claims should reflect the finished-formula evidence actually available.
Key takeaways
- Always name the exact vitamin C derivative.
- Separate stability and penetration from human visible outcomes.
- Combination studies cannot isolate one ingredient’s contribution.
- Concentrations are not interchangeable across derivatives.
- Finished-product performance depends on the complete formulation and use conditions.
About the author: Bathula Meghana is the Founder of GlowBareSkin, a science-backed, skinimalist skincare brand. She writes evidence-aware ingredient guides for consumers and beauty media.
Educational disclaimer: This article is general educational information and not medical advice. It does not diagnose or treat pigmentation, acne or other skin conditions, and it does not establish the performance of any individual product.
